FLAG vs FLAG-IDA: outcomes in relapsed/refractory acute leukemias

ConclusionsFLAG regimen was found superior to FLAG-IDA with better survival and subsequent transplant rate.

http://link.springer.com/10.1007/s00280-019-03792-8

Source: Cancer Chemotherapy and Pharmacology - May 3, 2019 Category: Cancer & Oncology Source Type: research

More News: Acute Leukemia | Bleeding | Bone Marrow Transplant | Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Hematology | Leukemia | Medical Ethics | Pakistan Health | Statistics | Study | Thrombocytopenia | Toxicology | Transplants